NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells

Oncogene

Volumn 22, Issue 1, 2003, Pages 90-97

  Bentires Alj, Mohamed ^c   Barbu, Veronique ^a   Fillet, Marianne ^c   Chariot, Alain ^c   Relic, Biserka ^c   Jacobs, Nathalie ^c   Gielen, Jacques ^c   Merville, Marie Paule ^c   Bours, Vincent ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c NONE

Author keywords

Apoptosis; Cancer; Chemotherapy; MDR1; NF B; Transcription factors

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MUTANT PROTEIN; TRANSCRIPTION FACTOR; ANTINEOPLASTIC AGENT; PRIMER DNA;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG UPTAKE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSACTIVATION; CELL CULTURE; COLON TUMOR; DRUG ANTAGONISM; GEL MOBILITY SHIFT ASSAY; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PLASMID;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; COLONIC NEOPLASMS; DAUNORUBICIN; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; NF-KAPPA B; P-GLYCOPROTEIN; PLASMIDS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0037427122     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206056     Document Type: Article

References (56)

1. Bargou RC, Emmerich F, Krappmann D, Bomert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dörken B. (1997). J. Clin. Invest. 100, 2961-2969.
2. Barkett M and Gilmore TD. (1999). Oncogene, 18, 6910-6924.
3. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
4. Beg AA, Sha WC, Bronson RT, Ghosh S and Baltimore D. (1995). Nature, 376, 167-170.
5. Bentires-Alj M, Hellin AC, Ameyar M, Chouaib S, Merville MP and Bours V. (1999). Cancer Res., 59, 811-815.
6. Bezombes C, Maestre N, Laurent G, Levade T, Bettaieb A and Jaffrezou JP. (1998). FASEB J., 12, 101-109.
7. Biedier JL. (1994). Cancer Res., 54, 666-678.
8. Bonizzi G, Dejardin E, Piret B, Piette J, Merville M-P and Bours V. (1996). Eur. J. Biochem., 242, 544-549.
9. Bosch I and Croop J. (1996). Biochim. Biophys. Acta, 1288, F37-F54.
10. Bours V, Bentires-Alj M, Hellin A, Viatour P, Robe P, Delhalle S, Benoit V and Merville M. (2000). Biochem. Pharmacol., 60, 1085-1089.
11. Bours V, Burd PR, Brown K, Villalobos J, Park S, Ryseck R-P, Bravo R, Kelly K and Siebenlist U. (1992). Mol. Cell. Biol., 12, 685-695.
12. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson J and Van der Saag P. (1995). Mol. Endo., 9, 401-412.
13. Dejardin E, Bonizzi G, Bellahcéne A, Castronovo V, Merville M-P and Bours V. (1995). Oncogene, 11, 1835-1841.
14. Gala JL, Noel H, Rodhain J, Ma DF and Ferrant A. (1995). J. Clin. Pathol., 48, 679-681.
15. Goldie JH (1992). The Chemotherapy Source Book. In: Perry MC (ed). The Chemotherapy Source Book. Williams & Wilkins: Baltimore, pp 54-66.
16. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W and Brodeur GM et al. (1989). J. Natl. Cancer Inst., 81, 116-124.
17. Gros P, Croop J and Housman D. (1986). Cell, 47, 371-380.
18. Hannun YA. (1994). J. Biol. Chem., 269, 3125-3128.
19. Hu Z, Jin S and Scotto KW. (2000). J. Biol. Chem., 275, 2979-2985.
20. Johnstone RW, Cretney E and Smyth MJ. (1999). Blood, 93, 1075-1085.
21. Karin M. (1999). Oncogene, 18, 6867-6874.
22. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A and Green DR. (1998). Mol. Cell, 1, 543-551.
23. Kolesnick R. (1992). Trends Cell. Biol., 2, 232-236.
24. Kolesnick R and Golde DW. (1994). Cell, 77, 325-328.
25. Kuo MT, Liu Z, Wei Y, Lin-Yee YC, Tatebe S, Mills GB and Unate H. (2002). Oncogene, 21, 1945-1954.
26. Lee JI, Ganster RW, Geller DA, Burckart G J, Thomson AW and Lu L. (1999). Transplantation, 68, 1255-1263.
27. Li Q, Van Antwerp D, Mercurio F, Lee KF and Verma IM. (1999). Science, 284, 321-325.
28. Ling V, Kartner N, Sudo T, Siminovitch L and Riordan JR. (1983). Cancer Treat. Rep., 67, 869-874.
29. Madden MJ, Morrow CS, Nakagawa M, Goldsmith ME, Fairchild CR and Cowan KH. (1993). J. Biol. Chem., 268, 8290-8297.
30. Marienfeld R, Neumann M, Chuvpilo S, Escher C, Kneitz B, Avots A, Schimpl A and Serfling E. (1997). Ear. J. Immunol., 27, 1601-1609.
31. Meyer S, Kohler NG and Joly A. (1997). FEBS Lett., 413, 354-358.
32. Ogretmen B and Safa AR. (1999). Biochemistry, 38, 2189-2199.
33. Ogretmen B and Safa AR. (2000). Biochemistry, 39, 194-204.
34. Ogura M, Takatori T and Tsuruo T. (1992). Nucleic Acids Res., 20, 5811-5817.
35. Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, Kuwano M and Kohno K. (1998). J. Biol. Chem., 273, 5997-6000.
36. Pahl HL. (1999). Oncogene, 18, 6853-6866.
37. Ray A and Prefontaine KE. (1994). Proc. Natl. Acad. Sci. USA, 91, 752-756.
38. Rayet B and Gelinas C. (1999). Oncogene, 18, 6938-6947.
39. Robinson LJ, Roberts WK, Ling TT, Lamming D, Sternberg SS and Roepe PD. (1997). Biochemistry, 36, 11169-11178.
40. Ros JE, Schuetz JD, Geuken M, Streetz K, Moshage H, Kuipers F, Manns MP, Jansen PL, Trautwein C and Muller M. (2001). Hepatology, 33, 1425-1431.
41. Ryan KM, Ernst MK, Rice NR and Vousden KH. (2000). Nature, 404, 892-897.
42. Sampath J, Sun D, Kidd VJ, Grenet J, Gandhi A, Shapiro LH, Wang Q, Zambetti GP and Schuetz JD. (2001). J. Biol. Chem., 276, 39359-39367.
43. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA and Baldwin ASJ. (1995). Mol. Cell. Biol., 15, 943-953.
44. Schmidt A, Hennighausen L and Siebenlist U. (1990). J. Virol, 64, 4037-4041.
45. Smyth MJ, Krasovskis E, Sutton VR and Johnstone RW. (1998). Proc. Natl. Acad. Sci. USA, 95, 7024-7029.
46. Sonneveld P, Lokhorst HM and Vossebeld P. (1997). Semin. Hematol., 34, 34-39.
47. Sovak MA, Bellas RE, Kim DW, Zanievski GJ, Rogers AE and Traish AM. (1997). J. Clin. Invest., 100, 2952-2960.
48. Sundseth R, MacDonald G, Ting J and King AC. (1997). Mol. Pharmacol., 51, 963-971.
49. Thevenod F, Friedmann JM, Katsen AD and Hauser IA. (2000). J. Biol. Chem., 275, 1887-1896.
50. Ueda K, Pastan I and Gottesman MM. (1987). J. Biol. Chem., 262, 17 432-17 436.
51. Um JH, Kang CD, Lee BG, Kim DW, Chung BS and Kim SH. (2001). Oncogene, 20, 6048-6056.
52. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
53. Wang C-Y, Mayo MW and Baldwin AS. (1996). Science, 274, 784-787.
54. Wang CY, Cusack Jr, JC, Liu R and Baldwin Jr, AS. (1999). Nat. Med., 5, 412-417.
55. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH and Sonenshein GE. (1996). EMBO J., 15, 4682-4690.
56. Zhou G and Kuo MT. (1997). J. Biol. Chem., 272, 15174-15183.